Bank Hits $7 Trillion in Assets
Good Morning Wake-Up Watchlisters! While you’re sipping coffee you’ll see stock futures were flat on Tuesday. Investors remain uncertain over the Israel-Iran conflict, and now traders will look to a series of talks from Federal Reserve Chairman Jerome Powell.
It’s no secret that markets are down right now, but the truth that there are still ways to profit even in volatile markets as long as you have the right strategy. So far this year, Bryan and Karim have posted an 83% win rate on 113 trades in The War Room. And as earnings season kicks off, they’re already getting positioned on several stocks.
Here’s a look at the top-moving stocks this morning.
Morgan Stanley (NYSE: MS)
Morgan Stanley is up 2.98% in premarket trading after reporting profits for the first quarter. The Wall Street bank finished strong asset growth, posting $7 trillion of client assets across wealth and investment management. It also reported net income of $3.4 billion in the three months ended March 31 compared to $3 billion at the same time last year.
Yesterday our Head Trading Tactician Bryan Bottarelli got positioned on MS in The War Room.
Click here to see the strategy Bryan uses that could double your money while you sleep.
UnitedHealth Group (NYSE: UNH)
UnitedHealth is up 6.59% in premarket after reporting strong first quarter earnings. Earnings per share of $6.91 per share beat analysts’ estimates of $6.61. Revenue came in at $99.8 billion, which beat forecasts of $99.2 billion.
Live Nation Entertainment (NYSE: LYV)
Live Nation Entertainment is down 8.19% premarket after a Wall Street Journal that said the Justice Department was preparing to sue the parent of Ticketmaster. The lawsuit alleges the company used its leverage for ticketing live events to undermine the competition. The suit could be filed as soon as next month, the Journal reported.
Tesla (Nasdaq: TSLA)
Tesla is down 2.20% in premarket trading after CEO Elon Musk said he plans to layoff 10% of Tesla’s global workforce. Aside from the layoffs, Tesla’s head of powertrain and energy engineering Drew Baglino is also stepping down. Baglino has been with the company for 18 years and investors wanted him to expand his role at the company rather than leaving it.
Johnson & Johnson (NYSE: JNJ)
Johnson & Johnson is down 0.70% in premarket trading after sales from its blockbuster psoriasis drug Stelara fell short of expectations.
Stelara sales came in at $2.45 billion in the first quarter, which were below expectations of $2.6 billion, according to LSEG data.
Those are the biggest stock movers for today.
Happy trading!
The Wake-Up Watchlist Research Team
